Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Quality of life and functional improvements with the IL-6 receptor inhibitor tocilizumab in patients with active rheumatoid arthritis despite DMARD therapy: The toward study Annual Meeting of the British-Society-Rheumatology/Spring Meeting of British Health Professional in Rheumatology Gomez-Reino, J. J., FAIRFAX, M. J., Pavelka, K., Alecock, E., Woodworth, T., Laughton, J., Eves, D., Genovese, M. C. OXFORD UNIV PRESS. 2008: II49–II49
View details for Web of Science ID 000254680900164